neurodegenerative-diseases-1920x640
Whitepaper

Targeted protein degradation: A novel therapeutic strategy for neurodegenerative diseases

Targeted protein degradation (TPD) offers a promising approach for treating neurodegenerative diseases by selectively degrading disease-linked proteins. Despite challenges in delivery and stability, advancements in TPD technologies show potential in addressing diseases like Alzheimer’s, Parkinson’s, and Huntington’s.

Get this White Paper and have details about:

  • Targets Undruggable Proteins
  • Complete Protein Elimination
  • Innovative Technologies
  • And more…

For research use only. Not for use in diagnostic procedures.

To view the full content please answer a few questions

By submitting my personal data, I acknowledge that Revvity Inc. and its affiliates (“Company”) will process my personal data provided above consistent with the Company’s Privacy Policy available here.

Download Resource

Targeted protein degradation: A novel therapeutic strategy for neurodegenerative diseases

Download Whitepaper